ArchiMed's MED II fund fully invested following Cube buyout

  • by


Healthcare-focused private equity house ArchiMed has secured a majority stake in Cube Biotech, a Germany-based developer of membrane proteins for drug discovery.



Source link

Leave a Reply

Your email address will not be published.